With a solid cash position and expected profitability by late 2026, Apellis stock is set for recovery. Read the latest ...

A terahertz gradient-index (GRIN) dual-polarized lens with wide-angle beam-steering is designed in this article. A novel GRIN distribution is designed by superi ...

Data show that diabetes-associated metabolic issues lead to kidney lipid accumulation, resulting in inflammation and fibrosis that cause progressive kidney damage and disease progression.Earlier data ...

In a further positive sign the ASX healthcare sector may be recovering, Morgans' senior healthcare analyst Scott Power has ...

Medically reviewed by David Ozeri, MD Focal segmental glomerulosclerosis (FSGS) describes a condition in which scarring damages some of your kidneys' glomeruli, the microscopic filters that help your ...

Medically reviewed by Alexis Appelstein, DO There is no cure for focal segmental glomerulosclerosis (FSGS), but the proper ...

Travere Therapeutics restructures to boost financial health, expands the kidney therapy pipeline, and sees rapid growth for ...

After years of rocking stages across the Midwest, Alpena’s own Katharsys Theory has announced their final performance will ...

LGND READ THE FULL LGND RESEARCH REPORT Ligand Pharmaceuticals, Inc. (NASDAQ:LGND) reported second quarter 2025 financial and ...

Jermaine Laing, from Miami Florida, also received one of Joe’s kidneys. He was diagnosed at 10 with Focal Segmental Glomerulosclerosis (FSGS) a kidney disease, he says the transplant was a second ...

The focal mechanism provides seismological constraints on the geological faults that generate the earthquakes and thus is important for regional seismotectonic research. Focal mechanism calculation ...

Investing.com -- Travere Therapeutics, Inc. (NASDAQ: TVTX) reported stronger-than-expected second quarter 2025 financial results on Wednesday, driven by significant growth in FILSPARI sales, sending ...